Selection of Patients for Anti-Epidermal Growth Factor Receptor Treatment in Colorectal Cancer: The Potential Pitfalls of Retrospective Analyses of RAS Mutations
- PMID: 26304896
- DOI: 10.1200/JCO.2015.62.2977
Selection of Patients for Anti-Epidermal Growth Factor Receptor Treatment in Colorectal Cancer: The Potential Pitfalls of Retrospective Analyses of RAS Mutations
Comment in
-
Reply to S. Debska-Szmich et al.J Clin Oncol. 2015 Oct 20;33(30):3518. doi: 10.1200/JCO.2015.62.4619. Epub 2015 Aug 24. J Clin Oncol. 2015. PMID: 26304910 No abstract available.
Comment on
-
Fluorouracil, leucovorin, and irinotecan plus cetuximab treatment and RAS mutations in colorectal cancer.J Clin Oncol. 2015 Mar 1;33(7):692-700. doi: 10.1200/JCO.2014.59.4812. Epub 2015 Jan 20. J Clin Oncol. 2015. PMID: 25605843 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
